Clinical Trial Update: Retinal Sensitivity in BRVO After Anti-VEGF Therapy [Phase 4]

View source ↗

Summary

An ongoing Phase 4 clinical trial is evaluating retinal sensitivity in patients with branch retinal vein occlusion receiving anti-VEGF therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion

Snippet

Sponsor: Fukushima Medical University | Conditions: Branch Retinal Vein Occlusion | Phase 4 | Status: UNKNOWN